Precision Diagnostics in Age-Related Hearing Loss: Emerging Molecular Biomarkers for Early Detection and Targeted Prevention
International Journal of General Medicine · 2026-08 · Volume 19 · 1-20
DOI: 10.2147/ijgm.s623974 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of General Medicine, 2026-08. Verfasst von Zihao Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, 315040, People's Republic o…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Age-related hearing loss (ARHL) is a prevalent neurosensory impairment. Traditional audiometry is post-symptomatic, fundamentally failing to capture the molecular deterioration that precedes clinical hearing decline by years. To address this gap, the clinical paradigm is urgently shifting toward precision medicine. This review summarizes emerging molecular biomarkers enabling the early detection, patient stratification, and targeted prevention of ARHL. We systematically evaluate the clinical measurability and diagnostic value of biomarkers across core pathological axes: cellular senescence, inner ear apoptosis, chronic inflammaging, oxidative stress, and genetic variants. Crucially, we highlight how these molecular signatures show preclinical promise as future actionable targets for personalized interventions, including novel anti-inflammatory, antioxidant, and gene therapies. Finally, we explore the future potential of integrating these preliminary indicators into comprehensive biomarker panels. We conceptualize a theoretical precision diagnostics framework that synthesizes genomic, inflammatory, and oxidative profiles. While acknowledging that current evidence is predominantly based on mechanistic and preclinical studies requiring extensive human clinical validation, this proposed framework aims to guide future translational research. Ultimately, this conceptual approach lays the groundwork for discovering early interventions that could delay disease progression and improve long-term auditory prognosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, 315040, People's Republic of China.
- Health Science Center, Ningbo University, Ningbo, People's Republic of China.
ORCID-Profile: Hongshuai Liu, Zhisen Shen
Zitieren
APA
Xia, Z., Lin, C., Wu, Y., Liu, H., Wu, L., & Shen, Z. (2026). Precision Diagnostics in Age-Related Hearing Loss: Emerging Molecular Biomarkers for Early Detection and Targeted Prevention. International Journal of General Medicine, Volume 19, 1-20. https://doi.org/10.2147/ijgm.s623974
Vancouver
Xia Z, Lin C, Wu Y, Liu H, Wu L, Shen Z. Precision Diagnostics in Age-Related Hearing Loss: Emerging Molecular Biomarkers for Early Detection and Targeted Prevention. International Journal of General Medicine. 2026;Volume 19:1-20. doi:10.2147/ijgm.s623974
BibTeX
@article{Xia2026,
author = {Xia, Zihao and Lin, Chen and Wu, Yi and Liu, Hongshuai and Wu, Linrong and Shen, Zhisen},
title = {Precision Diagnostics in Age-Related Hearing Loss: Emerging Molecular Biomarkers for Early Detection and Targeted Prevention},
journal = {International Journal of General Medicine},
year = {2026},
volume = {Volume 19},
pages = {1--20},
doi = {10.2147/ijgm.s623974}
}
EUVIMED